News

2017 May 11

Stem cell transplant in ethnic populations

Tsiporah B. Shore, MD, associate director of the Blood and Bone Marrow Transplant Program discusses stem cell transplantation in patients of multi-ethnic populations who have hematologic malignancies. Read more

Evi Giannakakou, PhD (left), and David Nanus, MD

2017 May 10

Next Generation

Evi Giannakakou, Ph.D., mentors tomorrow’s investigators. Read more

2017 May 10

SIRT6's ability to suppress cancer cell growth is explained

Ithaca affiliate Hening Lin, Ph.D., has elucidated the function of the SIRT6 proteins as tumor suppressors. Read more

2017 May 10

Ritchie reflects on research underway in Myeloproliferative Neoplasms

Ellen K. Ritchie, M.D., discusses the landscape of myeloproliferative neoplasms (MPNs). Read more

2017 May 10

Leonard highlights agents, approaches in pipeline for hematologic malignancies

John Leonard, M.D., discusses precision medicine, immunotherapy, CAR-T, and other emerging therapies in hematology. Read more

2017 May 10

Double-hit and double-expressor lymphomas

Sarah Rutherford, M.D., discusses the classification and prevalence of double-hit and double-expressor lymphomas. Read more

2017 May 10

Treating AYA patients with Hodgkin Lymphoma

Lisa Giulino Roth, M.D., discusses treating adolescent and young adult patients with Hodgkin lymphoma. Read more

2017 May 10

Midostaurin approval brings new hope in AML

Gail Roboz, M.D., discusses new and emerging treatments for acute myeloid leukemia (AML). Read more

Igor Tulchinsky, Chris Mason and Olivier Elemento

2017 May 09

Using big data to make big strides in medicine

Christopher Mason, Ph.D., explains how a new initiative funded by WorldQuant founder Igor Tulchinsky will help medical researchers make better predictions. Read more

2017 May 09

Classifying T-cell lymphomas

Jia Ruan, M.D., Ph.D., discusses the classification of T-cell lymphomas. Read more

2017 May 09

Next steps in myeloma include combo regimens and achieving MRD

Ruben Niesvizky, M.D., discusses some of the exciting changes that have occurred in the field of multiple myeloma. Read more

2017 May 09

A 'stronger, more holistic' impact

Olivier Elemento, Ph.D., is featured in an article about Cornell's NYC connections. Read more

2017 May 08

Two Weill winners of Pershing Square Sohn Prize

Juan Cubillos-Ruiz and Yimon Aye were among six scientists selected as prestigious Pershing Square Sohn Prize winners. Read more

2017 May 05

New Method Developed to More Accurately Model Colorectal Cancer

Researchers have long struggled to develop preclinical models of colorectal cancer in which the disease forms in the correct anatomical location. Now Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center... Read more

2017 May 05

Patient preferences with MCL treatment

Peter Martin, M.D., assistant professor of medicine, discusses preferences patients have for treatment of their mantle cell lymphoma (MCL). Read more

2017 May 05

Emergence of CAR T-cell therapy in hematologic cancers

John P. Leonard, M.D., discusses the emergence and potential of chimeric antigen receptor (CAR) T-cell therapy across hematologic malignancies. Read more

2017 May 05

New method developed to more accurately model colorectal cancer

Using stem cells and three-dimensional organoids, Lukas Dow, Ph.D., and colleagues have created a colon cancer model that more accurately reflects the progression of the disease. Read more

2017 May 05

Pioneering program teaches students how to commercialize medical technologies

Graduate student Neel Madhukar came in second place in an entrepreneurship competition for medical technologies. Read more

2017 May 05

Collaborative startup will monitor pathogens in hospital settings

Feature about Biotia, a startup offering microbial surveillance for hospitals, is a joint venture between Christopher Mason and colleagues at Cornell Tech. Read more

2017 May 02

Delaying starting age for mammography won’t reduce overdiagnoses

A survey of almost six million breast exams found not one case of untreated cancer had regressed by the next mammogram—refuting the notion that overdiagnosis could be reduced by delaying the starting age for mammography screening or increasing the interval between exams. Read more

News

Stem cell transplant in ethnic populations

Next Generation

SIRT6's ability to suppress cancer cell growth is explained

Ritchie reflects on research underway in Myeloproliferative Neoplasms

Leonard highlights agents, approaches in pipeline for hematologic malignancies

Double-hit and double-expressor lymphomas

Treating AYA patients with Hodgkin Lymphoma

Midostaurin approval brings new hope in AML

Using big data to make big strides in medicine

Classifying T-cell lymphomas

Next steps in myeloma include combo regimens and achieving MRD

A 'stronger, more holistic' impact

Two Weill winners of Pershing Square Sohn Prize

New Method Developed to More Accurately Model Colorectal Cancer

Patient preferences with MCL treatment

Emergence of CAR T-cell therapy in hematologic cancers

New method developed to more accurately model colorectal cancer

Pioneering program teaches students how to commercialize medical technologies

Collaborative startup will monitor pathogens in hospital settings

Delaying starting age for mammography won’t reduce overdiagnoses

Follow us on X

2022 Annual Report

2021 Annual Report

2018 Annual Report

2017 Annual Report

2016 Annual Report

Newsletters